Oshkosh (NYSE: OSK) Q2 profit dips, cash flow turns positive
Oshkosh Corporation (NYSE: OSK) reported Q2 2026 net sales of $2,915.1 million, up from $2,732.1 million, while net income fell to $183.2 million from $204.8 million, and diluted EPS declined to $2.92 from $3.16. For the first half, operating cash flow turned positive at $213.3 million versus a $305.7 million use in 2025. Remaining performance obligations were $12.3 billion, with $2.5 billion expected in the rest of 2026.
How this was made
The 30-second read
Why it matters
OSK’s earnings softness (lower net income and EPS) contrasts with a cash flow improvement (operating cash flow positive for the first half). Separately, deferred contract costs tied to the NGDV contract are estimated to exceed future profits on existing orders by about $75M, signaling potential margin pressure in the backlog.
Market read
Traders can reassess OSK’s near-term earnings power versus cash conversion and backlog profitability risk based on the disclosed 10-Q figures.
What to watch
The article highlights remaining performance obligations and deferred contract costs but does not quantify order intake, margin trajectory, or whether the NGDV loss estimate is changing, which could be the key driver for forward estimates.
Background
The piece summarizes Oshkosh’s Q2 2026 results and first-half cash flow, framed around contract accounting metrics (remaining performance obligations and deferred contract costs).
Ticker impact
Oshkosh reported Q2 2026 net income of $183.2M vs $204.8M, while first-half operating cash flow turned positive at $213.3M.
Near-term bias depends on how investors weigh improved operating cash flow versus lower EPS and the estimated loss embedded in deferred contract costs.
The article provides concrete financial datapoints (sales, net income/EPS, operating cash flow) plus a specific risk disclosure (deferred contract costs exceeding future profits by about $75M on existing orders).
Market effects
Defense and specialty vehicle peers may see read-across on contract profitability and cash conversion, especially where large deferred contract cost balances exist.
No specific regional impact is disclosed in the article.
No explicit global macro or international demand drivers are provided beyond company-specific contract metrics.
Counterpoint
Investors may treat the $75M estimated loss as contained within a large backlog and focus on the cash flow improvement as evidence of better working-capital dynamics.
Key entities
- companyOshkosh Corporation
Reported Q2 2026 net sales of $2,915.1M, net income of $183.2M, and first-half operating cash flow of $213.3M, plus contract risk metrics tied to NGDV.
